journal article·2025-10Open access

Mesoporous silica nanoparticle-based nanomedicine: Preparation, functional modification, and theranostic applications

Yuying Liu, Man Zhao, Meihua Zhang, Bin Yang, Yun-Kun Qi, Qinrui Fu

Abstract

Mesoporous silica nanoparticles (MSNs) have emerged as cornerstone biomaterials for nanomedicine due to their highly tunable physicochemical properties. This review highlights recent breakthroughs in MSN-based platforms for disease theranostics. We systematically outline fundamental synthesis strategies and detail how surface functionalization-imparting properties such as targeting, stimuli-responsiveness, and biomimicry-transforms MSNs from passive carriers into intelligent theranostic agents. The review then summarizes the major contributions of these engineered platforms across key diagnostic ( e.g. , advanced imaging) and therapeutic ( e.g. , targeted drug delivery, dynamic therapies) applications, underscoring their potential in tackling complex diseases. Finally, we address the critical challenges hindering clinical translation, including manufacturing scalability and long-term biocompatibility. We conclude by outlining future directions, such as integration with emerging modalities like immunotherapy, aimed at accelerating the bench-to-bedside transition of MSN-based nanomedicines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Lipid nanoparticle formulations for optimal RNA-Based topical delivery to murine airways10.1016/j.ejps.2022.106234 ↗
2. Nanomedicine and versatile therapies for cancer treatment, MedComm
3. Inorganic porous nanoparticles for drug delivery in antitumoral therapy10.1002/biot.202000150 ↗
4. Recent progress in targeted delivery vectors based on biomimetic nanoparticles10.1038/s41392-021-00631-2 ↗
5. Extravaganza of nanobiotechnology in the diagnosis and treatment of dementia patients10.2174/1385272827666221027103050 ↗
6. Nanoceria-based lateral flow immunoassay for hydrogen peroxide-free colorimetric biosensing for C-reactive protein10.1007/s00216-022-03877-z ↗
7. Chidamide stacked in magnetic polypyrrole nano-composites counter thermotolerance and metastasis for visualized cancer photothermal therapy10.1080/10717544.2022.2068697 ↗
8. Nanoparticles in the diagnosis and treatment of vascular aging and related diseases10.1038/s41392-022-01082-z ↗
9. Smart cancer nanomedicine for synergetic therapy10.2174/0109298673300897240602130258 ↗
10. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy10.1126/sciadv.abc7031 ↗
11. Obstacles and opportunities in a forward vision for cancer nanomedicine10.1038/s41563-021-01047-7 ↗
12. Delivering the power of nanomedicine to patients today10.1016/j.jconrel.2020.07.007 ↗
13. Toxicological impact of diclofenac sodium: hematological, biochemical and histopathological changes in male rats
14. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
15. Nanocarriers used in drug delivery to enhance immune System in cancer therapy10.3390/pharmaceutics13081167 ↗
16. Doxil®--the first FDA-approved nano-drug: lessons learned10.1016/j.jconrel.2012.03.020 ↗
17. Nanoparticles in the clinic: an update post COVID-19 vaccines10.1002/btm2.10246 ↗
18. Drugs loaded in bilosomes for the treatment of gastrointestinal cancers: a comprehensive review10.62476/abes.101111 ↗
19. Mesoporous silica-based nanoplatforms are Theranostic agents for the treatment of inflammatory disorders10.3390/pharmaceutics15020439 ↗
20. Mesoporous Silica Nanoparticles obtention, functionalization and biomedical applications: a review
21. Near-infrared inorganic nanomaterial-based nanosystems for photothermal therapy10.1039/D1NR00323B ↗
22. 2D MXene nanomaterials for versatile biomedical applications: current trends and future prospects10.1002/smll.202100946 ↗
23. Degradable Holey Palladium Nanosheets with highly active 1D nanoholes for synergetic phototherapy of hypoxic tumors10.1021/jacs.9b12929 ↗
24. Inorganic nanomaterials with intrinsic singlet oxygen generation for photodynamic therapy10.1002/advs.202102587 ↗
25. MOF-Derived nanoparticles with enhanced acoustical performance for efficient mechano-sonodynamic therapy10.1002/adma.202400142 ↗
26. Design and application of inorganic nanoparticles for sonodynamic cancer therapy10.1039/D0BM01875A ↗
27. State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy10.1039/D0TB02360D ↗
28. A metabolic multistage glutathione depletion used for tumor-specific chemodynamic therapy10.1021/acsnano.1c10231 ↗
29. Single-Atom catalysts in catalytic biomedicine10.1002/adma.201905994 ↗
30. Biodegradation-Mediated enzymatic activity-tunable molybdenum oxide nanourchins for tumor-specific Cascade catalytic therapy10.1021/jacs.9b13586 ↗
31. Inorganic nanoparticles in clinical trials and translations10.1016/j.nantod.2020.100972 ↗
32. A comprehensive review on mesoporous Silica nanoparticles: a novel pharmaceutical aid for drug delivery
33. Green synthesis and characterization of silver nanoparticles using Anchusa Officinalis: antimicrobial and cytotoxic potential10.2147/IJN.S511217 ↗
34. Synthesis and antibacterial evaluation of silver-coated magnetic iron Oxide/Activated carbon nanoparticles derived from Hibiscus esculentus10.3390/magnetochemistry11070053 ↗
35. Synthesis and characterization of activated carbon-supported magnetic nanocomposite (MNPs-OLAC) obtained from okra leaves as a nanocarrier for targeted delivery of morin hydrate10.3389/fphar.2024.1482130 ↗
36. Biosafety of mesoporous silica nanoparticles; towards clinical translation10.1016/j.addr.2023.115049 ↗
37. Mesoporous silica nanoparticles as an ideal platform for cancer immunotherapy: recent advances and future directions10.1002/adhm.202400323 ↗
38. Mesoporous silica materials as an emerging tool for cancer immunotherapy10.1002/advs.202200756 ↗
39. Carbon dot-silica nanoparticle composites for ultralong lifetime phosphorescence imaging in tissue and cells at room temperature10.1021/acs.chemmater.9b04120 ↗
40. Multimodal decorations of mesoporous silica nanoparticles for improved cancer therapy10.3390/pharmaceutics12060527 ↗
41. Engineering core-shell mesoporous silica and Fe(3)O(4)@Au nanosystems for targeted cancer therapeutics: a review10.1080/02648725.2022.2147685 ↗
42. Au Nanoparticles@Si Nanowire Oligomer Arrays for SERS: Dimers Are Best10.1021/acsami.4c10004 ↗
43. Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery10.1088/1361-6528/ad42a3 ↗
44. Iron Oxide@Mesoporous Silica Core-Shell nanoparticles as multimodal platforms for magnetic resonance imaging, magnetic hyperthermia, near-infrared light photothermia, and drug delivery10.3390/nano13081342 ↗
45. A review on the recent advancements of polymer-modified mesoporous silica nanoparticles for drug delivery under stimuli-trigger10.3390/polym17121640 ↗
46. Future of mesoporous Silica nanoparticles in nanomedicine: protocol for reproducible synthesis, characterization, lipid coating, and loading of therapeutics (Chemotherapeutic, proteins, siRNA and mRNA)10.1021/acsnano.3c07621 ↗
47. Engineered mesoporous silica-based core-shell nanoarchitectures for synergistic chemo-photodynamic therapies10.3390/ijms231911604 ↗
48. Tuned manganese-impregnated mesoporous silica nanoparticles as a pH-Responsive dual imaging probe10.1021/acsabm.4c01303 ↗
49. Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications
50. In vivo study of light-driven naproxen release from gated mesoporous silica drug delivery system10.1038/s41598-021-99678-y ↗
51. Development of mesoporous silica-based nanoprobes for optical bioimaging applications10.1039/D1BM00204J ↗
52. On the importance of physicochemical parameters of copper and aminosilane functionalized mesoporous silica for hydroxychloroquine release, Materials science & engineering. C10.1016/j.msec.2021.112438 ↗
53. The nanotopography of SiO(2) particles impacts the selectivity and 3D fold of bound allergens10.1039/D1NR05958K ↗
54. Involvement of miR-199a-5p-loaded mesoporous silica nanoparticle-polyethyleneimine-KALA in osteogenic differentiation10.1016/j.jds.2024.01.007 ↗
55. An update on mesoporous silica nanoparticle applications in nanomedicine10.3390/pharmaceutics13071067 ↗
56. Polymeric delivery of therapeutic nucleic acids10.1021/acs.chemrev.0c00997 ↗
57. Multifunctional mesoporous silica nanoparticles for biomedical applications10.1038/s41392-023-01654-7 ↗
58. Recent trends of mesoporous silica-based nanoplatforms for nanodynamic therapies
59. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy10.1016/j.jconrel.2021.10.005 ↗
60. Recent trends of biodegradable mesoporous silica based nanoplatforms for enhanced tumor theranostics10.1016/j.cclet.2024.110221 ↗
61. Smart mesoporous silica nanoparticles in cancer: diagnosis, treatment, immunogenicity, and clinical translation10.1002/smll.202408898 ↗
62. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics10.1186/s12645-024-00250-w ↗
63. pH-responsive rosuvastatin-loaded nanosystem with superoxide dismutase- and catalase-like properties for M1-to-M2 macrophage repolarization and synergistic anti-atherosclerosis effects
64. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)10.1016/j.biopha.2019.109561 ↗
65. Recent development of micro-nano carriers for oral antineoplastic drug delivery, Mater
66. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics10.1016/j.biomaterials.2020.120191 ↗
67. Gene regulation technologies for gene and cell therapy10.1016/j.ymthe.2025.04.004 ↗
68. Mesoporous silica nanoparticles for drug delivery10.1002/adfm.201902634 ↗
69. Nanoarchitectured structure and surface biofunctionality of mesoporous Silica nanoparticles10.1002/adma.201907035 ↗
70. Recent applications of mesoporous silica nanoparticles in gene therapy
71. Future of mesoporous Silica nanoparticles in nanomedicine: protocol for reproducible synthesis, characterization, lipid coating, and loading of therapeutics (Chemotherapeutic, proteins, siRNA and mRNA)10.1021/acsnano.3c07621 ↗
72. Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer10.1016/j.biomaterials.2023.122332 ↗
73. Precisely targeted nano‐controller of PD‐L1 level for non‐small cell lung cancer spinal metastasis immunotherapy10.1002/adhm.202200938 ↗
74. Mesoporous peroxidase nanozyme for synergistic chemodynamic therapy and chemotherapy10.1016/j.colsurfb.2022.112603 ↗
75. The facile formation of hierarchical mesoporous silica nanocarriers for tumor-selective multimodal theranostics10.1039/D1BM00564B ↗
76. The thermal/pH-sensitive drug delivery system encapsulated by PAA based on hollow hybrid nanospheres with two silicon source10.1080/09205063.2020.1861734 ↗
77. Silver-decorated mesostructured cellular silica foams as excellent antibacterial hemostatic agents for rapid and effective treatment of hemorrhage10.1016/j.msec.2020.111105 ↗
78. Mesoporous silica SBA-15 decreases hyperammonemia and affects the gene expression of mitogen-activated protein kinases in the prefrontal cortex of rats with bile duct ligation, Iran
79. pH-labile artificial natural killer cells for overcoming tumor drug resistance10.1016/j.jconrel.2022.10.042 ↗
80. Supramolecular self‐assembled nanoparticles for targeted therapy of myocardial infarction by enhancing cardiomyocyte mitophagy
81. Euryale ferox seed‐inspired superlubricated nanoparticles for treatment of osteoarthritis10.1002/adfm.201807559 ↗
82. Sol–Gel‐Based advanced porous Silica materials for biomedical applications10.1002/adfm.201909539 ↗
83. Transition-Metal-Based nanozymes: synthesis, mechanisms of therapeutic action, and applications in cancer treatment10.1021/acsnano.4c02265 ↗
84. Sol–gel‐based advanced porous silica materials for biomedical applications10.1002/adfm.201909539 ↗
85. Sol–Gel barium titanate nanohole array as a nonlinear metasurface and a photonic crystal10.1002/smll.202304355 ↗
86. Mesoporous silica nanoparticles as a potential nanoplatform: therapeutic applications and considerations10.3390/ijms24076349 ↗
87. Mesoporous silica nanoparticles‐based nanoplatforms: basic construction, current state, and emerging applications in anticancer therapeutics10.1002/adhm.202201884 ↗
88. Ultrasound‐Propelled nanomotors enable activatable Near‐Infrared‐II Fluorescence imaging‐guided synergistic oxygen‐independent and oxygen‐dependent sonodynamic therapy of atherosclerosis
89. An engineered nanoplatform with tropism toward irradiated glioblastoma augments its radioimmunotherapy efficacy10.1002/adma.202314197 ↗
90. Enantioselective oral absorption of molecular chiral mesoporous silica nanoparticles
91. Nanocrystalline WSe2 excels at high-performance anode for Na storage via a facile one-pot hydrothermal method10.1007/s42864-022-00170-5 ↗
92. Synthesis and mechanism of a new environment-friendly flame retardant (anhydrous magnesium carbonate) by hydrothermal method10.1016/j.apt.2022.103776 ↗
93. Preparation and characterization of Nd-Sb co-doped SnO2 nanoflower electrode by hydrothermal method for the degradation of norfloxacin10.1016/j.cej.2021.129266 ↗
94. Mesoporous silica nanoparticles containing copper or silver synthesized with a new metal source: determination of their structure parameters and cytotoxic and irritating effects10.1016/j.taap.2021.115685 ↗
95. Sustainable synthesis of NaX by quasi-solid phase conversion from coal fly ash10.1016/j.jece.2024.114413 ↗
96. Study on membrane electrolysis for the removal of Fe from the leachate of coal fly ash10.1016/j.jece.2025.117234 ↗
97. Facile hydrothermal assisted basic catalyzed sol gel synthesis for mesoporous Silica Nanoparticle from Alkali Silicate solutions using dual structural templates10.3390/gels10120839 ↗
98. Hantzsch reaction using copper nitrate hydroxide-containing mesoporous silica nanoparticle with C3N4 framework as a novel powerful and reusable catalyst10.1038/s41598-023-36059-7 ↗
99. In situ phagocyte-mediated deep tumor penetration assisted by ApoA-1 mimetic peptide-modified silicasome10.1016/j.nantod.2023.101864 ↗
100. Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer's disease10.1186/s12951-024-02543-z ↗